GATIFLOXACIN
Substance profile for UNII L4618BD7KJ, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Substance Identity#
- UNII
- L4618BD7KJ
- Preferred term
- GATIFLOXACIN
- Registry number
- 180200-66-2
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- 2C19H22FN3O4.3H2O
Chemical And Database Identifiers#
- SMILES
- O.O.O.COC1=C(N2CCNC(C)C2)C(F)=CC3=C1N(C=C(C(O)=O)C3=O)C4CC4.COC5=C(N6CCNC(C)C6)C(F)=CC7=C5N(C=C(C(O)=O)C7=O)C8CC8
- RxCUI
- 228476
- PubChem
- 5282384
- NCIt
- C29070
- INN ID
- 0
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| PubChem Compound | 5282384 | https://pubchem.ncbi.nlm.nih.gov/compound/5282384 |
| RxNorm | 228476 | https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=228476 |
| NCI Thesaurus | C29070 | https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29070 |
| FDA Substance Registration System | L4618BD7KJ | https://precision.fda.gov/uniisearch/srs/unii/L4618BD7KJ |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| gatifloxacin | ACTIVE MOIETY | L4618BD7KJ | These highlights do not include all the information needed to use ZYMAXID ® safely and effectively. See full prescribing information for ZYMAXID ® . ZYMAXID ® (gatifloxacin ophthalmic solution) 0.5% Initial U.S. Approval: 1999 | 2 | |
| gatifloxacin | ACTIVE INGREDIENT | L4618BD7KJ | These highlights do not include all the information needed to use ZYMAXID ® safely and effectively. See full prescribing information for ZYMAXID ® . ZYMAXID ® (gatifloxacin ophthalmic solution) 0.5% Initial U.S. Approval: 1999 | 2 | |
| gatifloxacin | ACTIVE INGREDIENT | L4618BD7KJ | ZYMAXID (GATIFLOXACIN) SOLUTION/ DROPS [ALLERGAN, INC.] | 4 | |
| GATIFLOXACIN | ACTIVE INGREDIENT | L4618BD7KJ | GATIFLOXACIN SOLUTION/ DROPS [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| gatifloxacin | ACTIVE INGREDIENT | L4618BD7KJ | GATIFLOXACIN SOLUTION/ DROPS [PACIFIC PHARMA] | 1 |